New Ovarian Cancer Drug Trial Under Way
could help women resistant to other medicines
F...f a new drug, phenoxodiol.
In previous studies, phenoxodiol
has shown some success in helping traditional chem... to fight cancer cells.
The Phase III study of phenoxodiol
will take place at 30 sites in the United States, ...
Drug stabilizes cancer growth
...cancer in 7 out of 10 patients while causing minimal side effects. The drug phenoxodiol
was given to patients with a variety of cancers that failed// standard chem...ansduction inhibitors, all designed to switch off certain cancer processes. phenoxodiol
was discovered by Novogen Ltd., Marshall Edwards' Australian parent company...
Phenoxodiol in Medical Technology
A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
OVATUREtrial.com Launched to Inform Patients with Recurrent Ovarian Cancer about the OVATURE Clinical Research Study
NEW CANAAN, Conn., Aug. 30 /PRNewswire-FirstCall/ -- A new website has
been launched to facilitate recruitment of patients to OVATURE (OVArian
TUmor REsponse), a Ph...
First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
...aughton said. In a prior Phase II clinical trial, phenoxodiol
was tested in
combination with either cisplatin or...py, were treated with
phenoxodiol and cisplatin or phenoxodiol
and paclitaxel, respectively. Of
21 patients in th...pe OVATURE in
the search box). About phenoxodiol: phenoxodiol
is being developed as a therapy for
late- stage, c...
New Research Results Show That Investigational Drug Phenoxodiol
Targets Cancer Protein, Causing Cancer Cell Death
...n the U.S. alone.
In studies conducted thus far, phenoxodiol
has exhibited an
excellent safety profile, with fe...held May 9-11, help explain the
mechanism by which phenoxodiol
induces cancer cell death. This new
research suppo...rre, Ph.D.
at Purdue University, which showed that phenoxodiol
the tumor-specific protein, tNOX, t...
Phenoxodiol in Biological Technology
New Report Just Published: World Prostate Cancer Therapeutics Market Report
Prostate Cancer II-57
Antisoma Reveals Results from AS1404 Phase II Clinical Trial
in HRPC II-57
Marshall Edwards Conducts Study on phenoxodiol
in Prostate Cancer II-58
Combination of Provenge(R) and Taxotere(R) Offer Better Results
for HRPC Patients II-58
Ambrilia Reveals Results ...
Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
... Australia, is developing a range of therapeutics across the fields
of oncology, cardiovascular disease and inflammatory diseases. More
information on phenoxodiol
and on the Novogen group of companies can be
found at http://www.marshalledwardsinc.com and http://www.novogen.com . Under U.S. law, a new drug c...